Impact of Perioperative Myocardial Infarction on Angiographic and Clinical Outcomes Following Coronary Artery Bypass Grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)
To access this article, please choose from the options below
This work was supported by the Duke Clinical Research Institute, Durham, North Carolina. The PREVENT-IV Trial was supported by Corgentech Inc., South San Francisco, California. Dr. Alexander, G. Hafley, Dr. Mahaffey, Dr. Mack, Dr. Kouchoukos, Dr. Goyal, Dr. Peterson, Dr. Gibson, Dr. Califf, Dr. Harrington, and Dr. Ferguson received research funding from Corgentech Inc. for their participation in PREVENT IV.
PII: S0002-9149(08)00748-0
doi:10.1016/j.amjcard.2008.04.069
© 2008 Elsevier Inc. All rights reserved.
